BDH Industries Ltd

BDH Industries Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

BDH Industries Ltd

₹ 580 3.01%
23 Jul - close price
bdhind.com BSE: 524828
About

Incorporated in 1935, BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticals[1]

Key Points

Business Overview:[1]
BDHIL is a full-service Contract Manufacturing Organization for production of Pharmaceutical, Oncological Products and associated packaging services. It is an exporter and manufacturer of therapeutic formulations covering a wide range of pharmaceuticals

Website BSE
  • Market Cap ₹ 334 Cr.
  • Current Price ₹ 580
  • High / Low ₹ 585 / 272
  • Stock P/E 30.9
  • Book Value ₹ 134
  • Dividend Yield 0.78 %
  • ROCE 20.5 %
  • ROE 14.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 27.0%

Cons

  • The company has delivered a poor sales growth of 10.8% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
22.72 18.31 19.35 21.06 27.11 16.26 16.23 16.20 17.82 18.62 18.96 29.34 29.03
20.20 16.35 16.18 17.57 23.30 14.30 13.18 12.67 14.75 16.50 15.63 25.11 24.82
Operating Profit 2.52 1.96 3.17 3.49 3.81 1.96 3.05 3.53 3.07 2.12 3.33 4.23 4.21
OPM % 11.09% 10.70% 16.38% 16.57% 14.05% 12.05% 18.79% 21.79% 17.23% 11.39% 17.56% 14.42% 14.50%
0.34 0.37 0.41 0.37 0.43 0.38 0.43 0.46 0.57 0.55 0.55 0.53 0.61
Interest 0.07 0.04 0.03 0.02 0.10 0.02 0.04 0.01 0.01 0.01 0.03 0.01 0.01
Depreciation 0.13 0.13 0.13 0.13 0.18 0.22 0.23 0.23 0.23 0.22 0.22 0.22 0.22
Profit before tax 2.66 2.16 3.42 3.71 3.96 2.10 3.21 3.75 3.40 2.44 3.63 4.53 4.59
Tax % 28.20% 25.00% 26.61% 25.07% 25.25% 25.24% 25.23% 25.07% 26.76% 25.00% 27.82% 22.96% 37.25%
1.91 1.62 2.51 2.78 2.96 1.57 2.41 2.81 2.49 1.83 2.62 3.49 2.88
EPS in Rs 3.32 2.81 4.36 4.83 5.14 2.73 4.19 4.88 4.32 3.18 4.55 6.06 5.00
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
44 46 43 41 52 59 57 69 74 86 67 96
40 42 38 36 45 51 49 60 64 73 55 82
Operating Profit 4 4 5 5 7 9 9 9 11 12 12 14
OPM % 9% 9% 11% 13% 14% 15% 15% 13% 15% 14% 17% 14%
1 2 1 1 1 1 1 1 1 2 2 2
Interest 0 0 0 0 1 1 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 4 5 5 5 7 8 9 10 11 13 12 15
Tax % 32% 33% 33% 27% 26% 27% 27% 24% 26% 25% 26% 29%
3 3 3 4 5 6 6 7 8 10 9 11
EPS in Rs 4.46 5.61 5.80 6.53 8.39 10.32 11.05 12.54 14.24 17.14 16.10 18.78
Dividend Payout % 39% 37% 36% 36% 34% 25% 28% 29% 28% 26% 28% 27%
Compounded Sales Growth
10 Years: 8%
5 Years: 11%
3 Years: 9%
TTM: 44%
Compounded Profit Growth
10 Years: 13%
5 Years: 11%
3 Years: 10%
TTM: 17%
Stock Price CAGR
10 Years: 21%
5 Years: 31%
3 Years: 44%
1 Year: 75%
Return on Equity
10 Years: 15%
5 Years: 15%
3 Years: 15%
Last Year: 15%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 18 21 23 25 28 32 37 43 49 56 63 71
9 9 8 8 13 9 9 2 5 9 1 2
19 15 17 18 18 18 19 18 20 23 17 20
Total Liabilities 52 52 54 57 66 65 71 69 80 93 87 99
13 13 23 23 22 21 20 20 19 20 20 19
CWIP 0 4 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
38 35 31 34 44 44 51 49 61 73 67 80
Total Assets 52 52 54 57 66 65 71 69 80 93 87 99

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
6 4 7 -0 -4 11 1 3 6 -2 15 -2
-0 -5 -5 0 1 1 1 1 0 -0 2 2
-3 -1 -3 -3 3 -6 -2 -8 0 1 -10 -2
Net Cash Flow 3 -1 -1 -2 0 6 -0 -4 7 -1 6 -2
Free Cash Flow 6 -0 1 -1 -4 11 1 4 6 -4 15 -2
CFO/OP 198% 146% 186% 21% -24% 153% 35% 64% 82% 11% 153% 8%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 81 64 67 63 89 68 96 76 82 121 78 120
Inventory Days 71 61 39 95 89 51 53 50 53 30 65 28
Days Payable 201 162 192 244 188 158 171 123 139 128 134 91
Cash Conversion Cycle -49 -37 -85 -85 -10 -39 -21 4 -5 23 9 58
Working Capital Days -76 -72 -90 -60 -29 -31 6 56 49 71 102 116
ROCE % 13% 15% 14% 14% 16% 19% 18% 18% 20% 21% 18% 20%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Export Sales Share
% of total sales

Log in to view insights

Please log in to see hidden values.

Login
Foreign Exchange Earnings
Rs lakhs
Number of permanent employees
employees
R&D Expenditure
Rs lakhs
Top customer (IPCA) revenue share
% of revenue
R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
49.67% 49.67% 49.67% 49.67% 49.67% 49.67% 49.67% 49.70% 49.70% 49.70% 49.70% 49.70%
0.00% 0.00% 0.00% 0.44% 0.28% 0.28% 0.28% 0.28% 0.28% 0.28% 0.28% 0.28%
50.33% 50.34% 50.34% 49.91% 50.06% 50.05% 50.05% 50.02% 50.04% 50.03% 50.01% 50.02%
No. of Shareholders 5,1655,1115,4325,2465,2495,0445,0025,0144,8894,8004,7464,587

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings